FindTrial
Sign In

The Study Aims To Determine The Use Of Chitosan Covered Gauze For Prevention Of Post Partum Hemorrhage ( Bleeding After Delivery) In Women At High Risk Of Uterine Atony.

A Comparative Study Of Chitosan Covered Gauze With Intramuscular Oxytocin Versus Intramuscular Oxytocin For Prevention Of Atonic Postpartum Hemorrhage In Women With Risk Of Uterine Atony. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/095456
Enrollment
60
Registered
2025-09-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O098- Supervision of other high risk pregnancies

Interventions

Intervention1: Use Of Chitosan Coated Gauze For Pevention Of Post Partum Hemorrhage In Risk Of Pregnancies With Uterine Atony.: The Chitosan coated gauze is packed within uterus after vaginal deliver

Sponsors

BLDEDU Shri Bm Patil medical college Hospital and Research Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Delivering viable babies with high-risk pregnancies who are prone to Postpartum haemorrhage. Maternal age of more than 18 years Grand multipara Hydramnios Hypertensive disorders of pregnancy Eclampsia Gestational Diabetes Mellitus Abruption Anemia Multiple gestation Prolonged labour

Exclusion criteria

Exclusion criteria: The use of Chitosan gauze only for vaginal lacerations. Patients undergoing caesarean section. Patients with Traumatic PPH. Adherant or retained placenta. Anamolous uterus. Suspected chorioamniotis.

Design outcomes

Primary

MeasureTime frame
To evaluate the blood loss during vaginal delivery when Chitosan coated gauze for prevention of of postpartum haemorrhage is used along with IM oxytocin in comparision to IM oxytocin aloneTimepoint: The amount of blood loss in PPH with and without application of uterine chitosan gauze in high-risk women is measured using brass vaginal drapes, weighing wet gauzes and clots. (1gm=1mL) Any other additional intervention or information, pharmacological or surgical are noted. Pre delivery and post delivery(after 72 hours ) Hemoglobin shall be recorded and difference noted.—

Secondary

MeasureTime frame
To assess the need for additional uterotonic drugs. To assess the need for surgical intervention Timepoint: ;To asses the need for additional uterotonic drugs. To assess the need for surgical intervention.Timepoint: . Pre delivery and post delivery(after 72 hours ) Hemoglobin shall be recorded and difference noted.—

Countries

India

Contacts

Public ContactDr Nikita Arali

Shri B M Patil Deemed To Be University

ryaliwal@bldedu.ac.in9845152240

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026